Pain

Latest News

Neurologic Manifestations Seen in Most Hospitalized With COVID-19

Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.

Cefaly Dual Migraine Treatment Now Available Over-the-Counter

Previously, the external trigeminal nerve stimulator was only available with a prescription.

Efficacy of Repetitive Intravenous Dihydroergotamine for Pediatric Refractory Migraine

Repetitive intravenous dihydroergotamine may be an effective therapy for children with status migrainous or chronic migraine, but without lasting benefit.

Timolol Eyedrops Evaluated for Acute Migraine Treatment

During the study, 50 migraine patients randomly received either topically applied timolol maleate ophthalmic solution, 0.5%, or placebo eyedrops.

Higher Odds of Migraines Seen Among Sexual Minorities

Migraine is more common among sexual-minority groups than individuals identifying as exclusively heterosexual.

Red Flags of Past Medical History Common in Patients With COVID-19 and Headache

While there was no universal one, red flags concerning prior medical history were present in almost all patients with COVID-19 who developed headache.

Headache May Be an Early, Isolated Feature of COVID-19

Headache may be an early symptom of COVID-19, and identifying patients with characteristic features may help provide early isolation and treatment.

Parent Behavior Impacts Adolescent Headache Frequency and Disability

Protective parenting behavior is associated with significantly greater frequency of adolescent headaches.

Lasmiditan Increases Odds of Freedom From Migraine Attacks

Lasmiditan is associated with greater odds of achieving pain freedom from migraine attacks compared with placebo.

Managing Analgesia in Critically Ill Patients Receiving Naltrexone

Researchers convened to develop recommendations on management of sedation and analgesia in critically ill patients receiving naltrexone for opioid use disorder.